
|Articles|January 11, 2022
- Pharmaceutical Executive-01-01-2022
- Volume 42
- Issue 1
Our View on 2022: Pharm Exec’s Annual Industry Outlook
Advertisement
Follow the links below to read about each trend:
Articles in this issue
over 4 years ago
Keeping Tabs on Quality: The Rise of Digitalover 4 years ago
China Invests in Building Biotechover 4 years ago
Branding Takes on a New Lookover 4 years ago
Addressing Access Burdensover 4 years ago
Meeting the Patient—Virtuallyover 4 years ago
The Age of Influenceover 4 years ago
Boosting Immunotherapiesover 4 years ago
Pharma’s Psychedelic Experienceover 4 years ago
Supply Chain Procurementover 4 years ago
Breaking New Ground in BiopharmaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
2
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
3
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
4
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
5




